Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.

Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F.

Eur Heart J Acute Cardiovasc Care. 2018 Oct 1:2048872618802783. doi: 10.1177/2048872618802783. [Epub ahead of print]

PMID:
30270638
2.

Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.

D'Ascenzo F, Grosso A, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Ali HH, Magnani G, Autelli M, Blanco PF, Garay A, Quadri G, Marra WG, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Raposeiras-Roubin S.

Int J Cardiol. 2018 Dec 15;273:29-33. doi: 10.1016/j.ijcard.2018.09.020. Epub 2018 Sep 6.

PMID:
30228021
3.

Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.

Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E.

Rev Esp Cardiol (Engl Ed). 2018 Jul 17. pii: S1885-5857(18)30222-6. doi: 10.1016/j.rec.2018.06.004. [Epub ahead of print] English, Spanish.

PMID:
30029980
4.

Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.

Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2018 Jun 25. pii: S1885-5857(18)30213-5. doi: 10.1016/j.rec.2018.05.021. [Epub ahead of print] English, Spanish.

PMID:
29954720
5.

Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.

Guerrero C, Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Kinnaird T, Manzano-Fernández S, Alegre O, Sánchez-Salado JC, Lorente V, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Conrotto F, Bertaina M, Autelli M, Grosso A, Blanco PF, Quadri G, Varbella F, Tomassini F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Alexopoulos D, Iñiguez-Romo A, Gaita F, Cequier Á.

Thromb Res. 2018 May 22;167:142-148. doi: 10.1016/j.thromres.2018.05.024. [Epub ahead of print]

PMID:
29857270
6.

Effectiveness and safety of rivaroxaban in a cohort of 142 patients with nonvalvular atrial fibrillation treated with rivaroxaban for the prevention of stroke.

Cerezo-Manchado JJ, Navarro-Almenzar B, Elvira-Ruiz G, García-Candel F, Flores-Blanco PJ, Caro-Martínez C, Manzano-Fernández S, García-Iniesta N, Sánchez-García J, Cabañas-Perianes V, Moraleda-Jiménez JM.

Future Cardiol. 2018 May;14(3s):31-37. doi: 10.2217/fca-2018-0024.

PMID:
29848091
7.

Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.

Caneiro-Queija B, Abu-Assi E, Raposeiras-Roubín S, Manzano-Fernández S, Flores Blanco P, López-Cuenca Á, Cobas-Paz R, Gómez-Molina M, Rodríguez-Rodríguez JM, Calvo-Iglesias F, Valdés-Chávarri M, Íñiguez-Romo A.

Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12. English, Spanish.

PMID:
29656987
8.

Kidney function monitoring and nonvitamin K oral anticoagulant dosage in atrial fibrillation.

Andreu Cayuelas JM, Caro Martínez C, Flores Blanco PJ, Elvira Ruiz G, Albendin Iglesias H, Cerezo Manchado JJ, Bailen Lorenzo JL, Januzzi JL, García Alberola A, Manzano-Fernández S.

Eur J Clin Invest. 2018 Jun;48(6):e12907. doi: 10.1111/eci.12907. Epub 2018 Apr 22.

PMID:
29423910
9.

Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome.

Flores-Blanco PJ, Cambronero-Sánchez F, Raposeiras-Roubin S, Abu-Assi E, Leithold G, Cobas-Paz R, Rodríguez Serrano AI, Calvo-Iglesias F, Valdés M, Januzzi JL, Iñiguez-Romo A, Manzano-Fernández S.

Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):538-544. doi: 10.1016/j.rec.2017.10.009. Epub 2017 Nov 14. English, Spanish.

PMID:
29146484
10.

Evaluation of the CRUSADE Risk Score for Predicting Major Bleeding in Patients with Concomitant Kidney Dysfunction and Acute Coronary Syndromes.

Sánchez-Martínez M, Flores-Blanco PJ, López-Cuenca ÁA, Sánchez-Galián MJ, Gómez-Molina M, Cambronero-Sánchez F, Guerrero-Pérez E, Valdés M, Januzzi JL, Manzano-Fernández S.

Cardiorenal Med. 2017 Jun;7(3):179-187. doi: 10.1159/000455102. Epub 2017 Feb 17.

11.

Causes and Predictors of Death in Atrial Fibrillation Patients Initiating Treatment With Direct Oral Anticoagulants.

Caro Martínez C, Andreu Cayuelas JM, Elvira Ruiz G, Albendín Iglesias H, García Alberola A, Manzano Fernández S.

Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):500-503. doi: 10.1016/j.rec.2017.03.032. Epub 2017 Jun 7. English, Spanish. No abstract available.

PMID:
28601413
12.

Inconclusive Exercise Stress Echocardiography in Patients With Chest Pain: Prevalence and Clinical Determinants.

Flores-Blanco PJ, Cambronero F, García-Navarro M, de la Morena G, Valdés M, Manzano-Fernández S.

Rev Esp Cardiol (Engl Ed). 2018 May;71(5):406-408. doi: 10.1016/j.rec.2017.02.042. Epub 2017 May 9. English, Spanish. No abstract available.

PMID:
28499844
13.

Impact of Autoimmune Disease on the Management and Prognosis of Acute Coronary Syndrome.

Lozano Rivas N, Pastor-Pérez FJ, Flores-Blanco PJ, Marras Fernández-Cid C, Linares LF, Manzano-Fernández S.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1145-1147. doi: 10.1016/j.rec.2017.03.018. Epub 2017 Apr 14. English, Spanish. No abstract available.

PMID:
28416289
14.

Comparison of Bleeding Risk Scores in Patients With Nonvalvular Atrial Fibrillation Starting Direct Oral Anticoagulants.

Caro Martínez C, Andreu Cayuelas JM, Flores Blanco PJ, Valdés M, Bailén Lorenzo JL, Manzano Fernández S.

Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):878-880. doi: 10.1016/j.rec.2017.01.021. Epub 2017 Feb 24. English, Spanish. No abstract available.

PMID:
28238647
15.

SAMe-TT2R2 Score: Useful in All Patients With Nonvalvular Atrial Fibrillation? Response.

Andreu-Cayuelas JM, Puche CM, Flores-Blanco PJ, Manzano-Fernández S.

Rev Esp Cardiol (Engl Ed). 2016 Aug;69(8):799. doi: 10.1016/j.rec.2016.04.026. Epub 2016 Jun 18. English, Spanish. No abstract available.

PMID:
27328997
16.

Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.

Flores-Blanco PJ, López-Cuenca Á, Januzzi JL, Marín F, Sánchez-Martínez M, Quintana-Giner M, Romero-Aniorte AI, Valdés M, Manzano-Fernández S.

Clin Cardiol. 2016 Sep;39(9):507-15. doi: 10.1002/clc.22556. Epub 2016 Jun 1.

17.

SAMe-TT2R2 Score Does Not Predict Time in Therapeutic Range in Atrial Fibrillation Patients After Hospitalization for Acute Decompensated Heart Failure.

Andreu-Cayuelas JM, Puche CM, Caro-Martínez C, Flores-Blanco PJ, Valdés M, Manzano-Fernández S.

Rev Esp Cardiol (Engl Ed). 2016 Apr;69(4):453-4. doi: 10.1016/j.rec.2016.01.009. Epub 2016 Feb 28. No abstract available.

PMID:
26935330
18.

Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes.

López-Cuenca A, Gómez-Molina M, Flores-Blanco PJ, Sánchez-Martínez M, García-Narbon A, De Las Heras-Gómez I, Sánchez-Galian MJ, Guerrero-Pérez E, Valdés M, Manzano-Fernández S.

J Geriatr Cardiol. 2016 Jan;13(1):15-22. doi: 10.11909/j.issn.1671-5411.2016.01.014.

19.

Comparison of the Global Registry of Acute Coronary Events Risk Score Versus the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse outcomes With Early Implementation of the ACC/AHA Guidelines Risk Score to Predict In-Hospital Mortality and Major Bleeding in Acute Coronary Syndromes.

Manzano-Fernández S, Sánchez-Martínez M, Flores-Blanco PJ, López-Cuenca Á, Gómez-Molina M, Pastor-Pérez FJ, Sánchez-Galian MJ, Cambronero-Sanchez F, Guerrero Pérez E, García-Narbón A, de Las Heras-Gómez I, Valdés M.

Am J Cardiol. 2016 Apr 1;117(7):1047-54. doi: 10.1016/j.amjcard.2015.12.048. Epub 2016 Jan 14.

PMID:
26857164
20.

Validation of a New Risk Score for Predicting Post-discharge Cardiovascular Events in Patients With Acute Coronary Syndrome.

Manzano-Fernández S, Flores-Blanco PJ, Gómez-Molina M, López-Cuenca ÁA, Sánchez-Galian MJ, Valdés M.

Rev Esp Cardiol (Engl Ed). 2016 Mar;69(3):338-40. doi: 10.1016/j.rec.2015.11.006. Epub 2016 Jan 14. No abstract available.

PMID:
26778589

Supplemental Content

Loading ...
Support Center